MediThinQ, Enters

MediThinQ Enters China Through Strategic Partnership with Sinopharm, Making Wearable Surgical Displays a Reality in Operating Theatres

07.08.2025 - 18:06:13 | prnewswire.co.uk

VentureBlick Singapore China

Group Med-Tech Co., Ltd.. "This innovation will not only enhance ergonomics for healthcare professionals and improve operating room efficiency, but also fundamentally transform how surgeons learn, train, and perform procedures. As the exclusive distributor of MediThinQ's XR surgical displays in China, Sinopharm is committed to playing a role in this transformation."

MediThinQ is supported by VentureBlick, a go-global partner for healthcare innovation. Chris Lee, Founder & CEO of VentureBlick said: "Bringing local medical technology to the global stage has always been our mission, and MediThinQ is a standout example of that vision in action. VentureBlick is proud to have supported MediThinQ's global expansion — from US to Europe, and now into China — laying a strong foundation to accelerate its worldwide adoption and long-term growth."

MediThinQ's momentum is powered by ongoing R&D breakthroughs, including the world's smallest portable 3D microscope and a next-generation digital loupe. It recently completed a successful USD 8.8 million Series B round, fuelling further innovation and market reach. The new partnership in China strengthens its leadership and marks a major step toward global expansion.

Photo - https://mma.prnewswire.com/media/2691502/SeungJoonIm__MediThinQ__and_Wang_Yiran__Sinopharm.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/medithinq-enters-china-through-strategic-partnership-with-sinopharm-making-wearable-surgical-displays-a-reality-in-operating-theatres-302459980.html

Hol dir jetzt den Wissensvorsprung der Aktien-Profis.

 <b>Hol dir jetzt den Wissensvorsprung der Aktien-Profis.</b>
Seit 2005 liefert der Börsenbrief trading-notes verlässliche Aktien-Empfehlungen - Dreimal die Woche, direkt ins Postfach. 100% kostenlos. 100% Expertenwissen. Trage einfach deine E-Mail Adresse ein und verpasse ab heute keine Top-Chance mehr. Jetzt abonnieren.
Für. Immer. Kostenlos
boerse | 67959992 |